Nifty
Sensex
:
:
15934.65
53228.28
-305.65 (-1.88%)
-980.25 (-1.81%)

Pharmaceuticals & Drugs - API

Rating :
52/99

BSE: 532482 | NSE: GRANULES

263.10
18-May-2022
  • Open
  • High
  • Low
  • Previous Close
  •  251.00
  •  265.45
  •  251.00
  •  250.75
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  2343577
  •  6101.74
  •  404.80
  •  232.10

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 6,523.79
  • 15.20
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 7,101.96
  • 0.57%
  • 2.65

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 41.98%
  • 4.29%
  • 24.55%
  • FII
  • DII
  • Others
  • 23.19%
  • 3.77%
  • 2.22%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.35
  • 18.08
  • 12.41

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 26.85
  • 23.40
  • 17.37

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 33.77
  • 31.49
  • 43.06

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 17.56
  • 15.96
  • 15.28

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.36
  • 2.82
  • 3.19

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.65
  • 10.57
  • 10.44

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 22
Mar 21
Var%
Dec 21
Dec 20
Var%
Sep 21
Sep 20
Var%
Jun 21
Jun 20
Var%
Net Sales
1,029.97
799.31
28.86%
996.77
844.51
18.03%
888.33
858.12
3.52%
849.85
735.60
15.53%
Expenses
837.27
597.31
40.17%
823.04
632.95
30.03%
737.15
601.71
22.51%
648.42
552.01
17.47%
EBITDA
192.70
202.01
-4.61%
173.73
211.56
-17.88%
151.18
256.41
-41.04%
201.43
183.59
9.72%
EBIDTM
18.71%
25.27%
17.43%
25.05%
17.02%
29.88%
23.70%
24.96%
Other Income
3.96
3.28
20.73%
4.87
16.41
-70.32%
4.35
3.22
35.09%
7.62
5.63
35.35%
Interest
6.36
6.82
-6.74%
4.59
7.24
-36.60%
5.46
6.27
-12.92%
6.79
5.95
14.12%
Depreciation
40.18
44.48
-9.67%
39.23
36.85
6.46%
39.84
36.06
10.48%
39.38
34.08
15.55%
PBT
150.12
153.99
-2.51%
134.78
183.88
-26.70%
110.23
217.30
-49.27%
162.87
149.19
9.17%
Tax
39.12
26.42
48.07%
33.90
37.08
-8.58%
29.55
53.67
-44.94%
42.67
37.74
13.06%
PAT
111.00
127.57
-12.99%
100.88
146.81
-31.29%
80.68
163.63
-50.69%
120.20
111.45
7.85%
PATM
10.78%
15.96%
10.12%
17.38%
9.08%
19.07%
14.14%
15.15%
EPS
4.48
5.15
-13.01%
4.07
5.93
-31.37%
3.26
6.61
-50.68%
4.85
4.51
7.54%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Net Sales
3,764.92
3,237.54
2,598.65
2,279.20
1,684.62
1,410.57
1,357.18
1,292.92
1,095.86
764.37
653.97
Net Sales Growth
16.29%
24.59%
14.02%
35.29%
19.43%
3.93%
4.97%
17.98%
43.37%
16.88%
 
Cost Of Goods Sold
1,883.64
1,391.28
1,280.93
1,255.56
896.32
679.63
725.03
746.95
645.25
466.92
414.36
Gross Profit
1,881.28
1,846.27
1,317.72
1,023.64
788.30
730.93
632.15
545.97
450.61
297.45
239.60
GP Margin
49.97%
57.03%
50.71%
44.91%
46.79%
51.82%
46.58%
42.23%
41.12%
38.91%
36.64%
Total Expenditure
3,045.88
2,382.31
2,073.33
1,895.16
1,406.20
1,111.73
1,081.29
1,084.31
937.57
679.35
574.68
Power & Fuel Cost
-
68.85
59.74
57.67
48.22
38.67
34.97
45.73
36.70
37.71
26.28
% Of Sales
-
2.13%
2.30%
2.53%
2.86%
2.74%
2.58%
3.54%
3.35%
4.93%
4.02%
Employee Cost
-
324.29
259.04
209.82
165.21
140.19
117.57
106.96
85.84
59.71
45.46
% Of Sales
-
10.02%
9.97%
9.21%
9.81%
9.94%
8.66%
8.27%
7.83%
7.81%
6.95%
Manufacturing Exp.
-
228.39
177.94
157.62
120.84
88.60
66.97
50.89
38.68
24.34
18.90
% Of Sales
-
7.05%
6.85%
6.92%
7.17%
6.28%
4.93%
3.94%
3.53%
3.18%
2.89%
General & Admin Exp.
-
172.28
125.63
99.96
83.05
67.65
60.38
59.84
44.42
26.96
21.31
% Of Sales
-
5.32%
4.83%
4.39%
4.93%
4.80%
4.45%
4.63%
4.05%
3.53%
3.26%
Selling & Distn. Exp.
-
159.80
112.17
91.84
83.08
81.37
67.75
71.70
85.04
61.70
47.62
% Of Sales
-
4.94%
4.32%
4.03%
4.93%
5.77%
4.99%
5.55%
7.76%
8.07%
7.28%
Miscellaneous Exp.
-
37.42
57.88
22.69
9.49
15.61
8.62
2.24
1.64
2.01
47.62
% Of Sales
-
1.16%
2.23%
1.00%
0.56%
1.11%
0.64%
0.17%
0.15%
0.26%
0.11%
EBITDA
719.04
855.23
525.32
384.04
278.42
298.84
275.89
208.61
158.29
85.02
79.29
EBITDA Margin
19.10%
26.42%
20.22%
16.85%
16.53%
21.19%
20.33%
16.13%
14.44%
11.12%
12.12%
Other Income
20.80
26.88
36.56
26.68
10.84
9.93
5.62
4.34
4.31
2.06
1.38
Interest
23.20
26.28
27.02
28.46
33.06
32.26
37.07
32.35
20.43
17.67
16.99
Depreciation
158.63
151.46
136.95
105.48
76.20
71.51
58.40
52.65
29.81
23.08
20.70
PBT
558.00
704.36
397.90
276.78
180.00
204.99
186.03
127.96
112.36
46.32
42.98
Tax
145.24
154.91
115.73
89.11
63.40
65.20
61.15
37.05
37.13
13.76
13.02
Tax Rate
26.03%
21.99%
27.19%
32.20%
35.22%
31.81%
32.87%
28.95%
33.05%
29.71%
30.29%
PAT
412.76
549.46
309.91
187.67
116.60
139.79
124.89
90.91
75.23
32.57
29.95
PAT before Minority Interest
412.76
549.46
309.91
187.67
116.60
139.79
124.89
90.91
75.23
32.57
29.95
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
10.96%
16.97%
11.93%
8.23%
6.92%
9.91%
9.20%
7.03%
6.86%
4.26%
4.58%
PAT Growth
-24.88%
77.30%
65.14%
60.95%
-16.59%
11.93%
37.38%
20.84%
130.98%
8.75%
 
EPS
16.64
22.16
12.50
7.57
4.70
5.64
5.04
3.67
3.03
1.31
1.21

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Shareholder's Funds
2,173.27
1,843.72
1,529.47
1,304.18
903.60
661.60
431.16
355.96
274.85
245.09
Share Capital
24.77
25.42
25.42
25.38
22.87
21.67
20.43
20.28
20.13
20.06
Total Reserves
2,126.23
1,800.02
1,493.09
1,273.38
878.28
611.13
410.74
335.43
254.41
225.03
Non-Current Liabilities
366.30
485.98
552.63
488.19
187.99
246.62
356.52
343.51
202.00
112.60
Secured Loans
333.81
414.83
478.78
433.13
123.90
183.66
302.59
295.86
174.85
87.30
Unsecured Loans
7.34
6.69
0.00
0.00
0.34
0.55
0.62
13.38
0.65
0.75
Long Term Provisions
24.84
21.50
12.58
7.70
7.25
5.58
4.03
3.97
2.04
1.53
Current Liabilities
1,173.10
893.40
896.48
877.91
787.13
654.75
415.03
292.54
205.78
213.63
Trade Payables
541.05
356.88
323.48
274.35
215.98
181.10
187.63
135.54
91.84
75.52
Other Current Liabilities
200.77
153.16
113.60
69.84
93.43
79.21
88.98
47.78
23.77
31.39
Short Term Borrowings
409.27
371.69
454.21
525.10
473.83
392.85
124.97
100.91
85.46
102.06
Short Term Provisions
22.01
11.66
5.20
8.62
3.90
1.58
13.45
8.30
4.71
4.66
Total Liabilities
3,712.67
3,223.10
2,978.58
2,670.28
1,878.72
1,562.97
1,202.71
992.01
682.63
571.32
Net Block
1,332.00
1,203.97
944.25
776.73
644.34
559.94
616.55
482.47
263.46
250.42
Gross Block
2,145.15
1,875.23
1,472.94
1,199.63
983.66
822.98
843.76
653.90
387.41
354.50
Accumulated Depreciation
813.15
671.26
528.69
422.90
339.32
263.05
227.21
171.43
123.95
104.07
Non Current Assets
1,715.68
1,594.41
1,696.34
1,483.71
1,050.55
744.97
699.69
611.55
388.87
310.52
Capital Work in Progress
239.08
294.20
495.95
514.52
267.43
76.56
62.03
124.56
108.80
29.30
Non Current Investment
18.99
19.34
210.42
156.56
108.23
70.11
0.19
0.19
0.19
0.19
Long Term Loans & Adv.
125.61
76.89
45.72
35.91
30.56
38.37
20.76
4.33
16.42
30.50
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
0.15
0.00
0.00
0.12
Current Assets
1,997.00
1,628.70
1,282.24
1,186.57
828.16
818.00
500.36
376.92
288.88
260.26
Current Investments
0.00
109.85
0.00
0.00
0.00
0.00
0.00
0.00
9.46
0.00
Inventories
782.18
438.43
384.21
279.95
269.18
253.72
224.52
174.16
136.48
109.91
Sundry Debtors
765.42
662.04
673.54
628.25
417.70
375.35
136.91
110.91
71.02
95.01
Cash & Bank
271.04
283.94
89.04
115.64
49.80
130.29
65.31
41.75
41.71
31.98
Other Current Assets
178.35
42.60
36.99
48.64
91.49
58.65
73.63
50.10
30.21
23.36
Short Term Loans & Adv.
127.61
91.83
98.46
114.09
51.66
48.68
2.05
28.76
16.93
13.18
Net Current Assets
823.90
735.30
385.76
308.65
41.03
163.25
85.33
84.38
83.09
46.63
Total Assets
3,712.68
3,223.11
2,978.58
2,670.28
1,878.71
1,562.97
1,202.72
992.01
682.64
571.31

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Cash From Operating Activity
432.48
476.19
262.24
-0.65
188.24
151.43
150.28
107.95
91.18
25.60
PBT
704.36
425.64
276.78
180.00
204.99
186.03
127.96
112.36
46.32
42.98
Adjustment
194.43
156.88
149.85
107.45
95.14
92.63
85.37
50.39
41.46
37.74
Changes in Working Capital
-274.95
12.75
-75.94
-230.03
-52.37
-79.70
-31.34
-31.03
14.60
-43.61
Cash after chg. in Working capital
623.84
595.27
350.69
57.42
247.77
198.97
182.00
131.73
102.39
37.11
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-191.37
-119.08
-88.45
-58.07
-59.53
-47.54
-31.72
-23.78
-11.20
-11.51
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-277.13
-160.63
-269.82
-462.31
-326.09
-161.65
-145.55
-254.63
-127.79
-54.47
Net Fixed Assets
-204.42
-124.57
-176.36
-282.01
-249.86
-75.62
-231.53
-64.60
-89.18
-54.67
Net Investments
-36.29
-48.78
-431.34
-0.01
13.84
-16.48
72.98
-94.69
-17.96
-10.20
Others
-36.42
12.72
337.88
-180.29
-90.07
-69.55
13.00
-95.34
-20.65
10.40
Cash from Financing Activity
-299.31
-212.85
-17.43
528.62
55.87
85.67
18.83
146.72
46.33
48.86
Net Cash Inflow / Outflow
-143.97
102.70
-25.01
65.66
-81.98
75.44
23.56
0.04
9.72
19.99
Opening Cash & Equivalents
185.93
83.02
108.03
42.37
124.35
54.85
41.75
41.71
31.98
11.99
Closing Cash & Equivalent
41.84
185.93
83.02
108.03
42.37
130.29
65.31
41.75
41.71
31.98

Financial Ratios

Consolidated /

Standalone
Description
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Mar 13
Mar 12
Book Value (Rs.)
86.85
71.80
59.73
51.17
39.40
29.20
20.98
17.36
13.40
12.19
ROA
15.84%
9.99%
6.64%
5.13%
8.12%
9.03%
8.31%
8.98%
5.19%
5.95%
ROE
27.64%
18.54%
13.32%
10.60%
18.23%
23.53%
23.29%
24.20%
12.67%
12.90%
ROCE
25.38%
17.22%
12.71%
11.09%
16.57%
20.16%
18.75%
19.90%
12.95%
14.89%
Fixed Asset Turnover
1.97
1.75
1.78
1.55
1.59
1.66
1.77
2.14
2.11
1.96
Receivable days
65.94
83.34
100.03
112.83
100.84
67.60
33.47
29.73
38.66
45.82
Inventory Days
56.39
51.34
51.03
59.23
66.49
63.11
54.79
50.77
57.37
50.89
Payable days
117.79
58.20
54.96
62.37
64.87
59.99
53.57
43.67
44.19
40.05
Cash Conversion Cycle
4.54
76.48
96.10
109.70
102.46
70.72
34.69
36.83
51.84
56.66
Total Debt/Equity
0.39
0.49
0.65
0.75
0.73
1.01
1.14
1.25
1.00
0.83
Interest Cover
27.80
16.75
10.72
6.44
7.36
6.02
4.96
6.50
3.62
3.53

News Update:


  • Granules India gets licences from MPP to market Nirmatrelvir, Ritonavir
    19th Mar 2022, 09:18 AM

    The licenses are applicable for both API and finished products, in tablet form, of nirmatrelvir, Ritonavir

    Read More
  • Granules India’s foreign subsidiary clears US FDA audit
    15th Mar 2022, 12:48 PM

    There were three minor observations during the inspection and GPI had addressed the observations in the stipulated time period

    Read More
  • Granules India - Quarterly Results
    8th Feb 2022, 13:46 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.